Navigation Links
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
Date:7/7/2008

results expressed or implied by such forward-looking statements. For example, the results of preclinical studies, including the toxicology studies described in this press release, may not be predictive of future results, and Anadys cannot provide any assurances that ANA773 or ANA598 will not have unforeseen safety issues in future toxicology studies, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving future products and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended March 31, 2008. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
2. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
3. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... VALLEY FORGE, Pa. , June 2, 2015 /PRNewswire/ ... plans to  build three new distribution centers in ... MN ; and Newburgh, NY ... strengthening the company,s ability to improve product access, increase ... Today,s announcement is part of the company,s ongoing ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... the addition of the "Electrophysiology Market by ... (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ... Global Forecasts to 2019" report to their ... is estimated to grow at a significant CAGR ...
(Date:6/2/2015)... June 2, 2015  Australian health technology company ... million to rapidly progress the company,s global ... (PKG™) mobile health technology. Foundation ... capital in the funding round. New investors ... net worth individuals and also the Israeli ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 2Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 3
... 31, 2011 NewCardio, Inc., (OTC Bulletin Board: ... today that the Company has been invited to present ... at an upcoming conference entitled "Cardiovascular Safety in Drug ... Drug Administration (FDA), the Cardiac Safety Research Consortium (CSRC) ...
... March 31, 2011 The Breast Journal ... of image-guided needle biopsy of suspicious breast cancer lesions ... the Naviscan high-resolution breast PET scanner, otherwise known as ... alone has been able to target regions in the ...
Cached Medicine Technology:NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 2NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 3NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 4NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 5NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 6Research on Crucial Role of PET-Guided Biopsy in Initial Breast Cancer Diagnosis and Presurgical Planning Published in The Breast Journal 2
(Date:6/2/2015)... Bitscape Infotech today announced it has ... Small and Midsized Cloud Solutions Award. The company was ... for demonstrating excellence in innovation and implementation of customer ... as no surprise to us as we feel our ... worldwide level by Microsoft. We will continue to lead ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... on a person. , According to Psychology Today, humans are ... to explain that curiosity is a part of human development. ...
(Date:6/2/2015)... TX, USA (PRWEB) June 02, 2015 ... microsystems, is deploying its growth strategy to benefit from ... BioMEMS: “In Yole Développement’s May 2015 Status of the ... will grow sharply and reach $6.6B in 2020,” says ... Yole Développement . , The analyst adds that ...
(Date:6/2/2015)... On October 1, 2015 the transition to ICD-10 will ... On Monday, June 1st Congressman Kevin Brady, chairman ... Means Committee, and 12 members of the Committee sent ... urging the administration to provide a smooth transition for ... the newest coding system for healthcare professionals to code ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Erbelli’s Gourmet ... website to promote its handmade gourmet pizzas and calzones, ... though the website is new, the recipes are not—they ... 1995. The main feature of the site is the ... pictures and descriptions of all the items. You can ...
Breaking Medicine News(10 mins):Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2
... The company behind Hello Kitty, the moon-faced cartoon cat turned ... worth 3.9 million yen (32,000 dollars) for the ultimate pampered ... 7,600 glass crystals and a cushion bearing Hello Kitty's face, ... later this month, Sanrio Co. said. ,Sanrio designer ...
... high-risk of having a heart attack are unclear about when ... an ambulance , argue a group of heart specialists in ... who die from coronary heart disease have had previous heart ... Foundation shows that 40% of the general population would not ...
... of heart disease gives a more accurate measure of how ... and which adults are most likely to benefit from treatment ... that in the general population without pre-existing cardiovascular disease or ... 75 in Britain at high risk of developing heart disease. ...
... exercise reduces inflammation a condition that is predictive of ... still not clear whether there is a definitive link. And ... is by no means fully understood. ,A recent ... of Illinois provides new evidence that may help explain some ...
... device company founded in 2004 to bring high performance ... markets, announced that vascular surgeons at the Krankenhaus Friedrichstadt ... their novel high performance vascular sealant, ArterX(TM). ... year old man suffering from vascular insufficiency of the ...
... response teams to combat diseases of all types in the ... formed to combat both contagious and non-contagious diseases in the ... health minister Ajay Vishnoi told IANS. ,He ... objective to compile survey work and immediate control of natural ...
Cached Medicine News:Health News:High-risk Patients Need Better Guidance on What is and Isnt a Heart Attack 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 3Health News:Exercise Reduces Inflammation 2Health News:Exercise Reduces Inflammation 3Health News:Exercise Reduces Inflammation 4Health News:Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant 2
... leader in automatic slide stainers. It offers ... slide staining, ending messy procedures. The instrument ... marrow and other body fluids. With the ... a superb cytocentrifuge with eight-slide capacity and ...
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in human serum....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
Medicine Products: